findmyKOL

Madhumati Kalavar, MD

Basic profile

Brookdale University Hospital and Medical Center

ORCIDNone on fileNPI↗
✓ Full record
RegionBrooklyn, NY · NortheastSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Madhumati Kalavar is an Oncology physician affiliated with Brookdale University Hospital and Medical Center. OpenAlex indexes 79 publications with 391 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
79publications

Distinct works indexed by OpenAlex.

391citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
44companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

566 Schenectady Ave
Brooklyn, NY 112031821

Telephone

718-483-8360

Provider last certified this registry record 3 Jun 2025.

View the NPPES registry record

Industry payments

44 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    38.8%
    Aromatase Inhibitor10.7%
    Anastrozole80%Letrozole20%
    Part D<11 patients
    Proteasome Inhibitor7.1%
    Bortezomib100%
    Part D<11 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    20.9%
    Serotonin-3 Receptor Antagonist12.7%
    Granisetron Hcl81%Ondansetron Hcl19%
    Part D<11 patients
    H2 blocker3.5%
    Famotidine100%
    Part D<11 patients

    + 2 more classes in this area

  • Blood & clotting

    15.6%
    Salt solutions8.4%
    Sodium Chloride100%
    Part D≥14 patients
    Factor Xa inhibitor7.3%
    Eliquis69%Xarelto31%
    Part D<11 patients
Where care is delivered (Part B)81.2% facility · 18.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”